alt Hacker NewsUntil recently, if you offered a pump that _could_ be controlled by another device (such as a phone) you would have to offer your own "controller" device, even if 99.9% of your customers have a phone already.
So, this companion device is kind of a thing that Insulet had to release. You'll see this with CGM's too -- there's a small companion device sold with the Dexcom G7 (the "controller"), even though everyone just uses their phone.
This is kind of a regulatory quirk; basically from the FDA's point of view you had to have a complete standalone system, that did not include the phone, in order to be able to prescribe it. I think they do not require companion devices any more, it's OK to release something that requires the user to have a phone.
Replies
Its also for security.. outside the US, you still cant use a regular phone with the omnipod.
So essentially, it's like this?
"we plan on users having a phone to connect to it and use primarily. FDA requires a primary/backup. well it's already phone-controlled, go find a phone that works with it. needs to be cheap, cuz no one will really use it anyway"
That makes a little more sense. I was imagining the development process involving both devices, rather than one device first, then determining what the second would be later.
Thanks for the insight!